Arich Enterprise Co., Ltd. (TPEX:4173)
17.15
+0.05 (0.29%)
Sep 8, 2026, 1:30 PM CST
Arich Enterprise Market Cap
Arich Enterprise has a market cap or net worth of 1.28 billion as of September 8, 2026. Its market cap has decreased by -30.71% in one year.
Market Cap
1.28B
Enterprise Value
938.52M
Revenue
1.56B
Ranking
n/a
PE Ratio
21.71
Stock Price
17.15
ChartMarket Cap Chart
Since July 10, 2012, Arich Enterprise's market cap has increased from 863.24M to 1.28B, an increase of 48.16%. That is a compound annual growth rate of 2.81%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2026 | 1.28B | -18.72% |
| Dec 31, 2025 | 1.57B | -4.09% |
| Dec 31, 2024 | 1.64B | 0.23% |
| Dec 29, 2023 | 1.64B | 13.44% |
| Dec 30, 2022 | 1.44B | 7.50% |
| Dec 30, 2021 | 1.34B | -28.29% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 549.12B |
| Lin BioScience | 144.70B |
| Caliway Biopharmaceuticals | 132.52B |
| Pell Bio-Med Technology | 87.93B |
| Acer Medical | 1.37B |
| Bioptik Technology Incorporation | 1.35B |
| GeneFerm Biotechnology | 1.25B |
| Abnova (Taiwan) | 1.24B |